Literature DB >> 25502631

Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.

Victoria C Wing1, Doris E Payer2, Sylvain Houle3, Tony P George4, Isabelle Boileau2.   

Abstract

Striatal dopamine (DA) is thought to have a fundamental role in the reinforcing effects of tobacco smoking and nicotine. Microdialysis studies indicate that nicotine also increases DA in extrastriatal brain areas, but much less is known about its role in addiction. High-affinity D2/3 receptor radiotracers permit the measurement of cortical DA in humans using positron emission tomography (PET). [(11)C]FLB-457 PET scans were conducted in 10 nicotine-dependent daily smokers after overnight abstinence and reinstatement of smoking. Voxel-wise [(11)C]-FLB-457-binding potential (BPND) in the frontal lobe, insula, and limbic regions was estimated in the two conditions. Paired t-tests showed BPND values were reduced following smoking (an indirect index of DA release). The overall peak t was located in the cingulate gyrus, which was part of a larger medial cluster (BPND change -12.1±9.4%) and this survived false discovery rate correction for multiple comparisons. Clusters were also identified in the left anterior cingulate cortex/medial frontal gyrus, bilateral prefrontal cortex (PFC), bilateral amygdala, and the left insula. This is the first demonstration of tobacco smoking-induced cortical DA release in humans; it may be the result of both pharmacological (nicotine) and non-pharmacological factors (tobacco cues). Abstinence increased craving but had minimal cognitive effects, thus limiting correlation analyses. However, given that the cingulate cortex, PFC, insula, and amygdala are thought to have important roles in tobacco craving, cognition, and relapse, these associations warrant investigation in a larger sample. [(11)C]FLB-457 PET imaging may represent a useful tool to investigate individual differences in tobacco addiction severity and treatment response.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502631      PMCID: PMC4397400          DOI: 10.1038/npp.2014.327

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  66 in total

1.  An automated method for the extraction of regional data from PET images.

Authors:  Pablo Rusjan; David Mamo; Nathalie Ginovart; Douglas Hussey; Irina Vitcu; Fumihiko Yasuno; Suhara Tetsuya; Sylvain Houle; Shitij Kapur
Journal:  Psychiatry Res       Date:  2006-06-21       Impact factor: 3.222

2.  Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.

Authors:  Marie-Claude Asselin; Andrew J Montgomery; Paul M Grasby; Susan P Hume
Journal:  J Cereb Blood Flow Metab       Date:  2006-05-24       Impact factor: 6.200

3.  "Pack year" smoking histories: what about patients who use loose tobacco?

Authors:  D M Wood; M G Mould; S B Y Ong; E H Baker
Journal:  Tob Control       Date:  2005-04       Impact factor: 7.552

4.  Estimating WAIS IQ from the Shipley Institute of Living Scale using continuously adjusted age norms.

Authors:  R A Zachary; M J Paulson; R L Gorsuch
Journal:  J Clin Psychol       Date:  1985-11

5.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Authors:  Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 6.  Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.

Authors:  Edward D Levin; F Joseph McClernon; Amir H Rezvani
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

7.  Nicotine sensitization of monkey striatal dopamine release.

Authors:  Edward F Domino; Hideo Tsukada
Journal:  Eur J Pharmacol       Date:  2009-02-14       Impact factor: 4.432

8.  Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; Zoe Allen-Martinez; David Scheibal; Anna L Abrams; Matthew R Costello; Judah Farahi; Sanjaya Saxena; John Monterosso; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2008-06-18       Impact factor: 7.853

9.  alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex.

Authors:  Phil D Livingstone; Jayaraman Srinivasan; James N C Kew; Lee A Dawson; Cecilia Gotti; Milena Moretti; Mohammed Shoaib; Susan Wonnacott
Journal:  Eur J Neurosci       Date:  2009-01-28       Impact factor: 3.386

10.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03
View more
  9 in total

Review 1.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

Review 2.  A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate.

Authors:  Thulasi Thiruchselvam; Saima Malik; Bernard Le Foll
Journal:  Am J Drug Alcohol Abuse       Date:  2016-11-30       Impact factor: 3.829

3.  Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study.

Authors:  Chihiro Murayama; Toshiki Iwabuchi; Yasuhiko Kato; Masamichi Yokokura; Taeko Harada; Takafumi Goto; Taishi Tamayama; Yosuke Kameno; Tomoyasu Wakuda; Hitoshi Kuwabara; Atsushi Senju; Sadahiko Nishizawa; Yasuomi Ouchi; Hidenori Yamasue
Journal:  Mol Psychiatry       Date:  2022-02-18       Impact factor: 13.437

4.  Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.

Authors:  Shuochi Wei; Dongmei Wang; Huixia Zhou; Luyao Xia; Yang Tian; Qilong Dai; Rongrong Zhu; Wenjia Wang; Dachun Chen; Meihong Xiu; Li Wang; Xiangyang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-26       Impact factor: 5.760

Review 5.  Application of cross-species PET imaging to assess neurotransmitter release in brain.

Authors:  Sjoerd J Finnema; Mika Scheinin; Mohammed Shahid; Jussi Lehto; Edilio Borroni; Benny Bang-Andersen; Jukka Sallinen; Erik Wong; Lars Farde; Christer Halldin; Sarah Grimwood
Journal:  Psychopharmacology (Berl)       Date:  2015-04-30       Impact factor: 4.530

6.  Nicotine dependence in Croatian male inpatients with schizophrenia.

Authors:  Marina Šagud; Bjanka Vuksan-Ćusa; Nenad Jakšić; Alma Mihaljević-Peleš; Maja Živković; Suzana Vlatković; Tea Prgić; Darko Marčinko; Wei Wang
Journal:  BMC Psychiatry       Date:  2018-01-22       Impact factor: 3.630

Review 7.  Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2019-03-18       Impact factor: 4.530

8.  Dynamic image denoising for voxel-wise quantification with Statistical Parametric Mapping in molecular neuroimaging.

Authors:  Stergios Tsartsalis; Benjamin B Tournier; Christophe E Graf; Nathalie Ginovart; Vicente Ibáñez; Philippe Millet
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

9.  The effects of oral smokeless tobacco administration on endurance performance.

Authors:  Thomas Zandonai; Enrico Tam; Paolo Bruseghini; Fabio Pizzolato; Loretta Franceschi; Massimo Baraldo; Carlo Capelli; Paola Cesari; Cristiano Chiamulera
Journal:  J Sport Health Sci       Date:  2016-12-28       Impact factor: 7.179

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.